Max G. Ostermeier

Max G. Ostermeier is the Co-founder and Managing Director at Implandata Ophthalmic Products. Max has also served as the CEO and Founder for Odicrain, a medical device start-up, detecting critical brain injuries, helping to save lifes, from January 2004 to December 2009. Additionally, they were the CEO and Founder for Vital Sensors GmbH/Inc., a cardiac device start-up for more efficient heart-failure treatment, from January 2003 to December 2006. Furthermore, they were the CEO and Founder for Cranium Telemetrics, a medical device spin-off developing disruptive products for hydrocephalus care, from January 2002 to December 2008. Lastly, they served as the General Manager for Proligo LLC / Proligo GmbH, a biotech company producing best in class DNA/RNA synthesis reagents, from January 1998 to December 2001.

Some individuals on their team include Kaweh Mansouri - Chief Medical Officer, Philipp Groß - Head of Production, and Wouter Van Drunen - Senior Engineer R&D & Clinical Trials.